Description

Valvular heart disease can cause impairment which can be quantitated using the AMA criteria.


 

Selection: A patient should have evidence of valvular heart disease based on physical examination, laboratory studies or other findings.

 

Parameters:

(1) functional class (using the 1964 NYHA criteria)

(2) therapy (diet, medication, surgery) and its effectiveness

(3) evidence of heart failure or ventricular dysfunction

(4) valvular stenosis and/or regurgitation severity

Functional Class

Therapy

Heart Failure or Ventricular Dysfunction

Valvular Disease

Impair-ment of the Whole Person

none with ordinary daily activities or moderately heavy physical exertion (functional class I)

continuous therapy not required

no signs of CHF; no signs of ventricular dysfunction or dilation

mild

0 - 9%

functional class II (none with ordinary daily activities but present with moderate exertion)

effective

no signs of CHF with therapy; chamber dys-function or dilatation present

moderate

10 – 29%

functional class III (slight to moderate discomfort with ordinary daily activities)

partially effective

some signs of CHF; chamber dysfunction or dilatation present

moderate or severe

30 – 49%

functional class IV (symptomatic at rest or with less than ordinary daily activities)

ineffective

signs of CHF; chamber dysfunction or dilatation present

moderate or severe

50 – 100%

 

where:

• For a permanent impairment surgical correction of the valvular disorder should not be feasible or advisable for some reason.

• A patient who has had a valve surgery performed is classified based upon residual symptoms. If permanent complications occurred from surgery, then these are combined with the impairment associated with the valvular disease.

• Patients may require intermittent antibiotic therapy as prophylaxis for prevention of endocarditis.

 


To read more or access our algorithms and calculators, please log in or register.